Globalpharma Signs 7 Strategic MoUs Advancing R&D, Manufacturing And Sustainability
Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has signed seven strategic Memorandums of Understanding (MoUs) with leading partners to strengthen its capabilities across research and development, manufacturing optimisation, financing and sustainable operations. The collaborations are structured across three strategic clusters — innovation and product development, manufacturing, […]
Read More →
